Table 3.

Treatment modality applied for study patients (n = 79).

	Non-MALT (n = 63)		MALT (n = 16)
	Stage I/II, IIE	Stage IV	Stage I/II, IIE	Stage IV
Conservative	27 (63%)	12 (67%)	7 (54%)	3 (100%)
CT	22	10	3	3
CT + RT	5	2	1
RT			3
Nonconservative	17 (37%)	7 (33%)	6 (46%)	0
Surgery + CT	16	6	4
Surgery + CT + RT	1	1	2

MALT: mucosa associated lymphoid tissue, CT: chemotherapy, and RT: radiotherapy.